Josh Seidenfeld
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Ambagon Therapeutics Inc. CIK 1819934 · P7
Filings (1)
-
Ambagon Therapeutics Inc.D · Feb 7, 2025 · P7 · Biotechnology$12MView filing →